Issued Patents 2023
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11851407 | Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPYL | Hayden T. Ravert, Daniel P. Holt, Ying Chen, Ronnie C. Mease, Hong Fan +1 more | 2023-12-26 |
| 11813340 | PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy | Ronnie C. Mease, Vivek Kumar, Sangeeta Ray, Michael Zalutsky, Ganesan Vaidyanathan | 2023-11-14 |
| 11814365 | PSMA targeted fluorescent agents for image guided surgery | Ronnie C. Mease, Ying Chen, Sangeeta Ray | 2023-11-14 |
| 11773182 | Development of new monoclonal antibodies recognizing human prostate-specific membrane antigen (PSMA) | Cyril Barinka, Zora Novakova, Catherine A. Foss | 2023-10-03 |
| 11739063 | DREADD actuators | Jordi Bonaventura, Juan Luis Gomez, Andrew Horti, Feng Hu, Michael Michaelides +1 more | 2023-08-29 |
| 11697804 | Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy | Jordan J. Green, Camila Gadens Zamboni, Hannah Vaughan, Il Minn | 2023-07-11 |
| 11661402 | PSMA-targeting compounds and uses thereof | Ronnie C. Mease, Ying Chen, Sangeeta Ray | 2023-05-30 |
| 11607466 | Tumor and immune cell imaging based on PD-L1 expression | Sridhar Nimmagadda, Samit Chatterjee, Wojciech Lesniak, Dhiraj Kumar | 2023-03-21 |